» Articles » PMID: 34193109

Formin-like Protein 2 Promotes Cell Proliferation by a P27-related Mechanism in Human Breast Cancer Cells

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2021 Jul 1
PMID 34193109
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Breast cancer is the leading cause of cancer-related deaths in females worldwide. Formin-like protein 2 (FMNL2) is a member of formin family that governs cytokinesis, cell polarity, morphogenesis and cell division. To our knowledge, the function of FMNL2 in breast cancer proliferation still remains uncovered.

Methods: Tumor immune estimation resource (TIMER) analysis was used to detect the correlation between FMNL2 and Ki67 in breast cancer tissues. Quantitative real-time transcription polymerase chain reaction (qRT-PCR) and western blotting were performed to analyze the expression in human breast cancer cells. Moreover, RNA interference (RNAi) and plasmids were performed to silence and overexpress FMNL2 and p27. The CCK8, MTT, cell counting, colony formation, and 5-ethynyl-2-deoxyuridine (EdU) incorporation assays were used to detect cell proliferation, respectively. Flow cytometry analysis was used to detect cell cycle distribution. Further, the distribution of p27 was examined using immunofluorescence.

Results: We found that FMNL2 expression was positively associated with Ki67 among collected breast cancer tissues and in TCGA database. Compared to lower proliferative cells MCF7 and T47D, FMNL2 was overexpressed in highly proliferative breast cancer cells MDA-MB-231, BT549 and SUM159, accompanied by reduced levels of p27 and p21, and elevated CyclinD1 and Ki67 expression. FMNL2 silencing significantly inhibited the cell proliferation of MDA-MB-231 and BT549 cells. Meanwhile, FMNL2 overexpression distinctly promoted the cell proliferation of MCF7 cells. Furthermore, FMNL2 suppressed the nuclear levels of p27 and promoted p27 proteasomal degradation in human breast cancer cells. The ubiquitination of p27 was inhibited by FMNL2 silencing in BT549 cells. Besides, p27 silencing markedly elevated Ki67 expression and cell viability, which could be blocked by additionally FMNL2 silencing in MDA-MB-231 and BT549 cells. Furthermore, overexpression of p27WT significantly reversed the increased levels of FMNL2 and Ki67, cell viability and cell cycle progression induced by FMNL2 overexpression in MCF7 cells. More importantly, compared to p27WT group, those effects could be significantly reversed by p27△NLS overexpression.

Conclusions: These results demonstrated that FMNL2 promoted cell proliferation partially by reducing p27 nuclear localization and p27 protein stability in human breast cancer cells, suggesting the pivotal role of FMNL2 in breast cancer progression.

Citing Articles

CIP/KIP and INK4 families as hostages of oncogenic signaling.

Csergeova L, Krbusek D, Janostiak R Cell Div. 2024; 19(1):11.

PMID: 38561743 PMC: 10985988. DOI: 10.1186/s13008-024-00115-z.


Characterization of Expression and Function of the Formins FHOD1, INF2, and DAAM1 in HER2-Positive Breast Cancer.

Peippo M, Gardberg M, Kronqvist P, Carpen O, Heuser V J Breast Cancer. 2023; 26(6):525-543.

PMID: 37985384 PMC: 10761758. DOI: 10.4048/jbc.2023.26.e47.


Role of PAX2 in breast cancer verified by bioinformatics analysis and validation.

Yang S, Gao W, Wang H, Zhang X, Mi Y, Ding Y Ann Transl Med. 2023; 11(2):58.

PMID: 36819548 PMC: 9929765. DOI: 10.21037/atm-22-6360.


LINC00839 promotes malignancy of liver cancer via binding FMNL2 under hypoxia.

Xie Y, Lin H, Wei W, Kong Y, Fang Q, Chen E Sci Rep. 2022; 12(1):18757.

PMID: 36335129 PMC: 9637198. DOI: 10.1038/s41598-022-16972-z.


FMNL2 suppresses cell migration and invasion of breast cancer: a reduction of cytoplasmic p27 via RhoA/LIMK/Cofilin pathway.

Jiao X, Wang B, Yang L, Zhao Q, Zhang M, Liu X Cell Death Discov. 2022; 8(1):155.

PMID: 35379791 PMC: 8980084. DOI: 10.1038/s41420-022-00964-z.


References
1.
Block J, Breitsprecher D, Kuhn S, Winterhoff M, Kage F, Geffers R . FMNL2 drives actin-based protrusion and migration downstream of Cdc42. Curr Biol. 2012; 22(11):1005-12. PMC: 3765947. DOI: 10.1016/j.cub.2012.03.064. View

2.
Breitsprecher D, Goode B . Formins at a glance. J Cell Sci. 2013; 126(Pt 1):1-7. PMC: 3603506. DOI: 10.1242/jcs.107250. View

3.
Chatterjee S, McCaffrey L . Emerging role of cell polarity proteins in breast cancer progression and metastasis. Breast Cancer (Dove Med Press). 2014; 6:15-27. PMC: 3929326. DOI: 10.2147/BCTT.S43764. View

4.
Deeks M, Hussey P, Davies B . Formins: intermediates in signal-transduction cascades that affect cytoskeletal reorganization. Trends Plant Sci. 2002; 7(11):492-8. DOI: 10.1016/s1360-1385(02)02341-5. View

5.
Shao H, Li Q, Shi T, Zhang G, Shao F . LINC00707 promotes cell proliferation and invasion of colorectal cancer via miR-206/FMNL2 axis. Eur Rev Med Pharmacol Sci. 2019; 23(9):3749-3759. DOI: 10.26355/eurrev_201905_17801. View